**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 10034-99-8 |Magnesium sulfate heptahydrate | ca.100 | unlisted |
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully
investigated.
Potential Health Effects
Eye:
May cause mild eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. The toxicological properties of this substance have not
been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties
of this substance have not been fully investigated.
Chronic:
Exposure to high concentrations may cause central nervous system
depression.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
Antidote:
The use of calcium gluconate to precipitate the oxalate should be
determined by only qualified medical personnel.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Material will not burn. During a fire, irritating
and highly toxic gases may be generated by thermal decomposition or
combustion.
Extinguishing Media:
Substance is noncombustible; use agent most appropriate to
extinguish surrounding fire. Use water spray, dry chemical, carbon
dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. Avoid contact with eyes, skin, and
clothing. Keep container tightly closed. Avoid ingestion and
inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 7487-88-9:
CAS# 10034-99-8:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: transparent
Odor: odorless
pH: Not available.
Vapor Pressure: < 0.1 mm Hg @ 20 deg C
Viscosity: Not available.
Boiling Point: Decomposes
Freezing/Melting Point: 1124 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: 1124 deg C
Solubility in water: Soluble in water.
Specific Gravity/Density: 2.66
Molecular Formula: MgSO4.7H2O
Molecular Weight: 246.4564
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases, sulfur oxides (SOx), including
sulfur oxide and sulfur dioxide.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 7487-88-9: OM4500000
CAS# 10034-99-8: OM4508000
LD50/LC50:
Not available.
Not available.
Carcinogenicity:
Magnesium sulfate anhydrous -
Not listed by ACGIH, IARC, or NTP.
Magnesium sulfate heptahydrate -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
WGK (Water Danger/Protection)
CAS# 7487-88-9: 0
CAS# 10034-99-8: 0
Canada
CAS# 7487-88-9 is listed on Canada's DSL List.
CAS# 10034-99-8 is listed on Canada's DSL List.
CAS# 7487-88-9 is not listed on Canada's Ingredient Disclosure List.
CAS# 10034-99-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 7487-88-9 is listed on the TSCA inventory.
CAS# 10034-99-8 is not on the TSCA Inventory because it is a hydrate.
It is considered to be listed if the CAS number for the anhydrous form
is on the inventory (40CFR720.3(u)(2)).
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
MSDS Creation Date: 7/14/1999 Revision #4 Date: 7/14/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
1,1',3,3,3',3'-Hexamethyl-4,4',5,5'-dibenzo-2,2'-indotricarbocyanine
| 23178-67-8 |
|
1-Bromooctane, 97% (gc)
| 111-83-1 |
|
n-Octyl 4-chloroacetoacetate, tech. 85%
| 41051-21-2 |
|
Magnesium Hydroxide
| 1309-42-8 |
|
5-Nitrosalicylic Acid, 99%
| 96-97-9 |
|
Quinaldine red, 99% (uv-vis)
| 117-92-0 |
|
Silver nitrite, 99%
| 7783-99-5 |
|
Magnesium nitrate hexahydrate
| 10377-60-3 |
|
2,4-Dichloronitrobenzene, 97%
| 611-06-3 |
|
Magnesium Oxide
| 1309-48-4 |
|
Magnesium Perchlorate Anhydrous
| 10034-81-8 |
|
Pyrrole, 99%
| 109-97-7 |
|
Dextro,levo-10-camphorsulfonic acid, sodium salt, 98%
| 34850-66-3 |
|
2-Amino-4,6-Dihydroxy-5-Methylpyrimidine 99%
| 55477-35-3 |
|
N-Carbobenzyloxy-L-Valine, 99+%
| 1149-26-4 |
|
Calcium bromide dihydrate, 99+%
| 7789-41-5 |
|
Phenyl Acridine-9-Carboxylate
| 109392-90-7 |
|
(R,R)-(-)-2,3-Dimethoxy-1,4-Bis(Dimethylamino)Butane, 96%
| 26549-22-4 |
|
Magnesium sulfate anhydrous
| 7487-88-9 |
|
Guanidine carbonate, 97% (titr.)
| 593-85-1 |
|
4-Ethoxy-3-Methoxybenzaldehyde, 95%
| 120-25-2 |
|
Magnesium sulfate heptahydrate
| 7487-88-9 |
|
3-(N-Benzyl-N-methylamino)-1,2-propanediol 96+%
| 60278-98-0 |
|
Maleic acid
| 110-16-7 |
|
Malonic acid
| 141-82-2 |
|
Oil for Heat Transfer
| 0-01-1 |
|
D-(+)-Maltose Monohydrate
| 69-79-4 |
|
Manganese(II) chloride tetrahydrate
| 7773-01-5 |
|
2-Aminobenzimidazole, 95% (titr.)
| 934-32-7 |
|
Manganese (IV) Dioxide
| 1313-13-9 |
|
Cesium Fluoride, 99%
| 13400-13-0 |
|
2,2'-Dipyridylamine, 99%
| 1202-34-2 |
|
Manganese (II) Nitrate Solution
| 7697-37-2 |
|
Methylglyoxal bis-(guanyl-hydrazone) dihydrochloride monohydrate,
| 24968-67-0 |
|
N-Methyl-D-Glucamine, 99%
| 6284-40-8 |
|
1,5-Dibromopentane, 97%
| 111-24-0 |
|
Manganese(II) sulfate monohydrate
| 7785-87-7 |
|
Pentachloropyridine, 98%
| 2176-62-7 |
|
Mannitol
| 69-65-8 |
|
N,N-Dimethyl-O-Phenylenediamine Dihydrochloride, 99% (Titr.)
| 62654-07-3 |
|
Trimethyltin chloride, 99%
| 1066-45-1 |
|
Salicylamide, 99%
| 65-45-2 |
|
5-alpha-Cholestane, 98+%
| 481-21-0 |
|
2-Methyl-5-nitroimidazole, 99%
| 88054-22-2 |
|
2-Mercaptoethanol
| 60-24-2 |
|
Mercury(II) acetate
| 1600-27-7 |
|
Cytidine-2'(3')-Monophosphoric Acid, 99+%
| 84-52-6 |
|
Cis-2-Hydroxy-1-Cyclopentanecarboxamide 99+%
| 40481-98-9 |
|
Fast Blue B Salt
| 14263-94-6 |
|
M-Nitrocinnamic Acid, 99%, Predominantly Trans
| 555-68-0 |
|
|